40 research outputs found

    Π­Ρ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ компрСссионной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Π² ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠ΅ Π²Π΅Π½ΠΎΠ·Π½Ρ‹Ρ… тромбоэмболичСских ослоТнСний Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с COVID-19

    Get PDF
    Background The main method for preventing thrombotic complications in patients with coronavirus infection is anticoagulant therapy (ACT). However, its use is not always possible, in particular in patients with bleeding. The only method of prevention in this case is elastic compression (EC) of the lower extremities.Aim of study To evaluate the effectiveness of lower extremity EC for the prevention of venous thromboembolic complications (VTEC) in patients with a new coronavirus infection.Material and methods The study was approved by the local Ethics Committee of the Ryazan State Medical University of the Ministry of Health of Russian Federation and registered on the ClinicalTrials.gov platform (identifier NCT05143567). The study included 69 patients without prophylactic compression (Group 1) and 65 patients who used prophylactic compression stockings (Group 2). The patients were treated in the covid hospital from July to November 2021. All patients had verified coronavirus infection, they took ACT and underwent ultrasound duplex scanning of the veins of the lower extremities upon admission, in the intensive care unit and upon discharge. We assessed the frequency of venous thromboembolic complications (VTEC), hemorrhagic complications, and mortality. To assess the severity of bleeding, the classification of the Committee of the International Society on Thrombosis and Haemostasis (ISTH) was used.Results In patients without prophylactic compression (Group 1) there were 7 VTEC cases (10.14%); deep vein thrombosis (DVT) β€” 4 (5.8%), pulmonary embolism (PE) β€” 3 (4.3%). All 6 cases (8.7%) with PE were fatal. It was noted that 2 cases of PE (2.8%) were verified upon autopsy, and not clinically. In patients of the 2nd group with the use of elastic compression, the overall incidence of VTEC was only one case (1.6%). When analyzing the frequency of bleeding in the 1st group, there was one pulmonary bleeding (1.4%), in the 2nd group there was also one case of intense intermuscular hematoma (1.6%). Significant bleeding was observed in one patient (1.4%) of the 1st group, and in 3 (4.8%) cases of the 2nd group. The minor bleeding was observed in 11 patients (15.9%) of the 1st group, and in 8 (12.7%) patients of the 2nd group. The mortality during hospitalization was 11 (15.9%) cases in patients of the 1st group (without EC) and 7 (11.1%) in patients of the 2nd group (with EC) (p=0.419).Conclusions The mortality in patients with coronavirus infection without compression therapy is higher than in patients with compression stockings (p=0.419). Patients wearing compression stockings in the hospital had a low incidence of VTEC (1.6% of cases in group 2 versus 10.14% of cases in group 1, p=0.039). The study groups had the same frequency of bleeding (group 1 β€” one case (1.4%), group 2 β€” one case (1.6%). The use of preventive compression at the inpatient stage of treatment of a new coronavirus infection makes it possible to prevent VTEC in patients with bleeding when anticoagulant therapy is not possible.ΠΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ ΠžΡΠ½ΠΎΠ²Π½Ρ‹ΠΌ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠΈ тромботичСских ослоТнСний Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… коронавирусной ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠ΅ΠΉ являСтся антикоагулянтная тСрапия (АКВ). Однако ΠΈ Π΅Π΅ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π½Π΅ всСгда Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ, Π² частности, Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с кровотСчСниями. ЕдинствСнным способом ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠΈ Π² Π΄Π°Π½Π½ΠΎΠΌ случаС являСтся эластичСская компрСссия (ЭК) Π½ΠΈΠΆΠ½ΠΈΡ… конСчностСй.ЦСль Ρ€Π°Π±ΠΎΡ‚Ρ‹ ΠžΡ†Π΅Π½ΠΈΡ‚ΡŒ ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ примСнСния ЭК Π½ΠΈΠΆΠ½ΠΈΡ… конСчностСй Π² ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠ΅ Π²Π΅Π½ΠΎΠ·Π½Ρ‹Ρ… тромбоэмболичСских ослоТнСний (Π’Π’Π­Πž) Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π½ΠΎΠ²ΠΎΠΉ коронавирусной ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠ΅ΠΉ.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹ ИсслСдованиС ΠΎΠ΄ΠΎΠ±Ρ€Π΅Π½ΠΎ Π»ΠΎΠΊΠ°Π»ΡŒΠ½Ρ‹ΠΌ этичСским ΠΊΠΎΠΌΠΈΡ‚Π΅Ρ‚ΠΎΠΌ Π€Π“Π‘ΠžΠ£ Π’Πž Π ΡΠ·Π“ΠœΠ£ ΠœΠΈΠ½Π·Π΄Ρ€Π°Π²Π° России ΠΈ зарСгистрировано Π½Π° ΠΏΠ»Π°Ρ‚Ρ„ΠΎΡ€ΠΌΠ΅ ClinicalTrials.gov (ΠΈΠ΄Π΅Π½Ρ‚ΠΈΡ„ΠΈΠΊΠ°Ρ‚ΠΎΡ€ NCT05143567). Π’ исслСдованиС Π²ΠΊΠ»ΡŽΡ‡Π΅Π½Ρ‹ 69 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π±Π΅Π· примСнСния Ρ‚Ρ€ΠΈΠΊΠΎΡ‚Π°ΠΆΠ° (1-я Π³Ρ€ΡƒΠΏΠΏΠ°) ΠΈ 65 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ², ΠΊΠΎΡ‚ΠΎΡ€Ρ‹ΠΌ примСнялся профилактичСский компрСссионный Ρ‚Ρ€ΠΈΠΊΠΎΡ‚Π°ΠΆ (2-я Π³Ρ€ΡƒΠΏΠΏΠ°). Π‘ΠΎΠ»ΡŒΠ½Ρ‹Π΅ ΠΏΡ€ΠΎΡ…ΠΎΠ΄ΠΈΠ»ΠΈ Π»Π΅Ρ‡Π΅Π½ΠΈΠ΅ Π² ΠΊΠΎΠ²ΠΈΠ΄Π½ΠΎΠΌ госпиталС с июля ΠΏΠΎ Π½ΠΎΡΠ±Ρ€ΡŒ 2021 Π³. ВсС ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Ρ‹ Π±Ρ‹Π»ΠΈ с Π²Π΅Ρ€ΠΈΡ„ΠΈΡ†ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠΉ коронавирусной ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠ΅ΠΉ, ΠΈΠΌ Π½Π°Π·Π½Π°Ρ‡Π°Π»ΠΈ АКВ ΠΈ ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΡƒΠ»ΡŒΡ‚Ρ€Π°Π·Π²ΡƒΠΊΠΎΠ²ΠΎΠ΅ дуплСксноС сканированиС Π²Π΅Π½ Π½ΠΈΠΆΠ½ΠΈΡ… конСчностСй ΠΏΡ€ΠΈ поступлСнии, Π² ΠΎΡ‚Π΄Π΅Π»Π΅Π½ΠΈΠΈ Ρ€Π΅Π°Π½ΠΈΠΌΠ°Ρ†ΠΈΠΈ ΠΈ ΠΏΡ€ΠΈ выпискС. ΠžΡ†Π΅Π½ΠΈΠ²Π°Π»ΠΈ частоту Π²Π΅Π½ΠΎΠ·Π½Ρ‹Ρ… тромбоэмболичСских ослоТнСний (Π’Π’Π­Πž), гСморрагичСскиС ослоТнСния, Π»Π΅Ρ‚Π°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ. Для ΠΎΡ†Π΅Π½ΠΊΠΈ тяТСсти ΠΊΡ€ΠΎΠ²ΠΎΡ‚Π΅Ρ‡Π΅Π½ΠΈΠΈ использовали ΠΊΠ»Π°ΡΡΠΈΡ„ΠΈΠΊΠ°Ρ†ΠΈΡŽ ΠšΠΎΠΌΠΈΡ‚Π΅Ρ‚Π° ΠœΠ΅ΠΆΠ΄ΡƒΠ½Π°Ρ€ΠΎΠ΄Π½ΠΎΠ³ΠΎ общСства ΠΏΠΎ Ρ‚Ρ€ΠΎΠΌΠ±ΠΎΠ·Ρƒ ΠΈ гСмостазу (International Society on Thrombosis and Haemostasis, ISTH).Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ Π£ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π±Π΅Π· Ρ‚Ρ€ΠΈΠΊΠΎΡ‚Π°ΠΆΠ° (1-я Π³Ρ€ΡƒΠΏΠΏΠ°) Π’Π’Π­Πž составили 7 случаСв (10,14%); Ρ‚Ρ€ΠΎΠΌΠ±ΠΎΠ· Π³Π»ΡƒΠ±ΠΎΠΊΠΈΡ… Π²Π΅Π½ (Π’Π“Π’) β€” 4 (5,8%), тромбоэмболия Π»Π΅Π³ΠΎΡ‡Π½ΠΎΠΉ Π°Ρ€Ρ‚Π΅Ρ€ΠΈΠΈ (ВЭЛА) β€” 3 (4,3%). ВсС 6 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² (8,7%) с ВЭЛА β€” со ΡΠΌΠ΅Ρ€Ρ‚Π΅Π»ΡŒΠ½Ρ‹ΠΌ исходом. ΠžΡ‚ΠΌΠ΅Ρ‡Π΅Π½ΠΎ, Ρ‡Ρ‚ΠΎ 2 случая ВЭЛА (2,8%) Π±Ρ‹Π»ΠΈ Π²Π΅Ρ€ΠΈΡ„ΠΈΡ†ΠΈΡ€ΠΎΠ²Π°Π½Ρ‹ Π½Π° аутопсии, Π° Π½Π΅ клиничСски.Π£ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² 2-ΠΉ Π³Ρ€ΡƒΠΏΠΏΡ‹ с ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ эластичСской компрСссии общая частота Π’Π’Π­Πž составила всСго ΠΎΠ΄ΠΈΠ½ случай (1,6%). ΠŸΡ€ΠΈ Π°Π½Π°Π»ΠΈΠ·Π΅ частоты ΠΊΡ€ΠΎΠ²ΠΎΡ‚Π΅Ρ‡Π΅Π½ΠΈΠΉ Π² 1-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ Π±Ρ‹Π»ΠΎ ΠΎΠ΄Π½ΠΎ Π»Π΅Π³ΠΎΡ‡Π½ΠΎΠ΅ ΠΊΡ€ΠΎΠ²ΠΎΡ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ (1,4%), Π²ΠΎ 2-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ Ρ‚Π°ΠΊΠΆΠ΅ ΠΎΠ΄ΠΈΠ½ случай напряТСнной ΠΌΠ΅ΠΆΠΌΡ‹ΡˆΠ΅Ρ‡Π½ΠΎΠΉ Π³Π΅ΠΌΠ°Ρ‚ΠΎΠΌΡ‹ (1,6%). Π—Π½Π°Ρ‡ΠΈΠΌΡ‹Π΅ кровотСчСния Π² 1-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ наблюдались Ρƒ ΠΎΠ΄Π½ΠΎΠ³ΠΎ больного (1,4%), Π° Π²ΠΎ 2-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ β€” Ρƒ 3 (4,8%). ΠœΠ°Π»Ρ‹Π΅ кровотСчСния Π² 1-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ ΠΎΡ‚ΠΌΠ΅Ρ‡Π΅Π½Ρ‹ Ρƒ 11 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² (15,9%), Π²ΠΎ 2-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ β€” Ρƒ 8 (12,7%). Π›Π΅Ρ‚Π°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ Π²ΠΎ врСмя госпитализации Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² 1-ΠΉ Π³Ρ€ΡƒΠΏΠΏΡ‹ (Π±Π΅Π· ЭК) составила 11 Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… (15,9%) , Π²ΠΎ 2-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ (с ЭК) β€” 7 (11,1%) (Ρ€=0,419).Π’Ρ‹Π²ΠΎΠ΄Ρ‹ Π›Π΅Ρ‚Π°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с коронавирусной ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠ΅ΠΉ Π±Π΅Π· компрСссионной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Π²Ρ‹ΡˆΠ΅, Ρ‡Π΅ΠΌ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ компрСссионного Ρ‚Ρ€ΠΈΠΊΠΎΡ‚Π°ΠΆΠ° (Ρ€=0,419). Π£ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ², Π½ΠΎΡΠΈΠ²ΡˆΠΈΡ… компрСссионныС Ρ‡ΡƒΠ»ΠΊΠΈ Π² стационарС, ΠΎΠ±Π½Π°Ρ€ΡƒΠΆΠ΅Π½Π° низкая частота развития Π’Π’Π­Πž (1,6% случаСв Π²ΠΎ 2-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ ΠΏΡ€ΠΎΡ‚ΠΈΠ² 10,14% случаСв Π² 1-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅, Ρ€=0,039). Π’ исслСдуСмых Π³Ρ€ΡƒΠΏΠΏΠ°Ρ… Π±Ρ‹Π»Π° одинаковая частота Π±ΠΎΠ»ΡŒΡˆΠΈΡ… ΠΊΡ€ΠΎΠ²ΠΎΡ‚Π΅Ρ‡Π΅Π½ΠΈΠΉ (1-я Π³Ρ€ΡƒΠΏΠΏΠ° β€” ΠΎΠ΄ΠΈΠ½ случай (1,4%), 2-я Π³Ρ€ΡƒΠΏΠΏΠ° β€” ΠΎΠ΄ΠΈΠ½ (1,6%) случай). ΠŸΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ профилактичСского Ρ‚Ρ€ΠΈΠΊΠΎΡ‚Π°ΠΆΠ° Π½Π° стационарном этапС лСчСния Π½ΠΎΠ²ΠΎΠΉ коронавирусной ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ позволяСт Π²Ρ‹ΠΏΠΎΠ»Π½ΡΡ‚ΡŒ ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΡƒ Π’Π’Π­Πž Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с кровотСчСниями ΠΏΡ€ΠΈ нСвозмоТности провСдСния антикоагулянтной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ

    Poster display II clinical general

    Get PDF

    Π’ΠΏΠ»ΠΈΠ² Π†Π’ сСктору Π½Π° Π΅ΠΊΠΎΠ½ΠΎΠΌΡ–ΠΊΡƒ ΠΊΡ€Π°Ρ—Π½ΠΈ: ΠΏΡ€ΠΈΠΊΠ»Π°Π΄ Π’Ρ–Ρ€ΠΌΠ΅Π½Ρ–Ρ—

    No full text
    Π£ статті дослідТСно Π²ΠΏΠ»ΠΈΠ² Ρ–Π½Ρ„ΠΎΡ€ΠΌΠ°Ρ†Ρ–ΠΉΠ½ΠΈΡ… Ρ– Ρ‚Π΅Π»Π΅ΠΊΠΎΠΌΡƒΠ½Ρ–ΠΊΠ°Ρ†Ρ–ΠΉΠ½ΠΈΡ… Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³Ρ–ΠΉ (Π†ΠšΠ’) Π½Π° Π΅ΠΊΠΎΠ½ΠΎΠΌΡ–ΠΊΡƒ Π’Ρ–Ρ€ΠΌΠ΅Π½Ρ–Ρ—, здійснСно ΠΏΡ€ΠΎΠ³Π½ΠΎΠ· Ρ—Ρ— подальшого Ρ€ΠΎΠ·Π²ΠΈΡ‚ΠΊΡƒ Π½Π° основі досвіду ΠΊΡ€Π°Ρ—Π½-Π»Ρ–Π΄Π΅Ρ€Ρ–Π² Ρƒ Π³Π°Π»ΡƒΠ·Ρ– Π†ΠšΠ’. Π— ΠΌΠ΅Ρ‚ΠΎΡŽ систСматизації Π΅ΠΊΠΎΠ½ΠΎΠΌΡ–Ρ‡Π½ΠΈΡ…, ΠΏΠΎΠ»Ρ–Ρ‚ΠΈΡ‡Π½ΠΈΡ… Ρ– ΡΠΎΡ†Ρ–Π°Π»ΡŒΠ½ΠΈΡ… ΠΏΠ΅Ρ€Π΅Π²Π°Π³ Ρ€ΠΎΠ·Π²ΠΈΡ‚ΠΊΡƒ Π†ΠšΠ’ Π°Π²Ρ‚ΠΎΡ€ΠΈ ΠΏΡ€ΠΎΠ°Π½Π°Π»Ρ–Π·ΡƒΠ²Π°Π»ΠΈ досвід ΠΊΡ€Π°Ρ—Π½-Π»Ρ–Π΄Π΅Ρ€Ρ–Π² Ρƒ Π†Π’ сСкторі. На основі Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ–Π² Π°Π½Π°Π»Ρ–Π·Ρƒ Ρ‚Π΅Π½Π΄Π΅Π½Ρ†Ρ–ΠΉ Ρ€ΠΎΠ·Π²ΠΈΡ‚ΠΊΡƒ Π΅ΠΊΠΎΠ½ΠΎΠΌΡ–ΠΊΠΈ Π’Ρ–Ρ€ΠΌΠ΅Π½Ρ–Ρ— Π°Π²Ρ‚ΠΎΡ€ΠΈ сформували основні ΠΏΠ΅Ρ€Π΅Π΄ΡƒΠΌΠΎΠ²ΠΈ Ρ—Ρ— ΠΏΠ΅Ρ€Π΅ΠΎΡ€Ρ–Ρ”Π½Ρ‚Π°Ρ†Ρ–Ρ— Π· урахуванням наявних Ρ‚Π° ΠΌΠΎΠΆΠ»ΠΈΠ²ΠΈΡ… ΠΏΠ΅Ρ€Π΅Π²Π°Π³ Π²Ρ–Π΄ ΠΏΠΎΡˆΠΈΡ€Π΅Π½Π½Ρ Π†ΠšΠ’. Π£ статті ΠΏΡ–Π΄ΠΊΡ€Π΅ΡΠ»ΡŽΡ”Ρ‚ΡŒΡΡ, Ρ‰ΠΎ світова Π΅ΠΊΠΎΠ½ΠΎΠΌΡ–ΠΊΠ° ΠΏΠ΅Ρ€Π΅Ρ…ΠΎΠ΄ΠΈΡ‚ΡŒ Π²Ρ–Π΄ Ρ–Π½Π΄ΡƒΡΡ‚Ρ€Ρ–Π°Π»ΡŒΠ½ΠΎΡ— Π΄ΠΎ Ρ–Π½Ρ„ΠΎΡ€ΠΌΠ°Ρ†Ρ–ΠΉΠ½ΠΎΡ— (заснованої Π½Π° знаннях) Π΅ΠΏΠΎΡ…ΠΈ, Π΄Π΅ Π†ΠšΠ’ ΡΡ‚Π°ΡŽΡ‚ΡŒ Π½Π°ΠΉΠ³ΠΎΠ»ΠΎΠ²Π½Ρ–ΡˆΠΈΠΌΠΈ рСсурсами Ρƒ порівнянні Π· Ρ€ΠΎΠ±ΠΎΡ‡ΠΎΡŽ силою Ρ– ΠΊΠ°ΠΏΡ–Ρ‚Π°Π»ΠΎΠΌ. ΠœΠ΅Ρ‚ΠΎΡŽ статті Ρ” Π°Π½Π°Π»Ρ–Π· ΠΎΠ±'Ρ”ΠΊΡ‚ΠΈΠ²Π½ΠΈΡ… Ρ– суб'Ρ”ΠΊΡ‚ΠΈΠ²Π½ΠΈΡ… Π΅ΠΊΠΎΠ½ΠΎΠΌΡ–Ρ‡Π½ΠΈΡ… Ρ– ΠΏΠΎΠ»Ρ–Ρ‚ΠΈΡ‡Π½ΠΈΡ… ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌ Π’Ρ–Ρ€ΠΌΠ΅Π½Ρ–Ρ—, Π° Ρ‚Π°ΠΊΠΎΠΆ ΠΎΡ†Ρ–Π½ΠΊΠ° ΠΏΠΎΡ‚Π΅Π½Ρ†Ρ–Π°Π»Ρƒ Ρ—Ρ— Π΅ΠΊΠΎΠ½ΠΎΠΌΡ–Ρ‡Π½ΠΎΠ³ΠΎ Ρ€ΠΎΠ·Π²ΠΈΡ‚ΠΊΡƒ, заснованого Π½Π° Ρ€ΠΎΠ·Π±ΡƒΠ΄ΠΎΠ²Ρ– Π†ΠšΠ’. На основі Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ–Π² дослідТСння Π°Π²Ρ‚ΠΎΡ€Π°ΠΌΠΈ Π±ΡƒΠ»ΠΎ сформовано систСму ΠΏΠ΅Ρ€ΡˆΠΎΡ‡Π΅Ρ€Π³ΠΎΠ²ΠΈΡ… Π·Π°Ρ…ΠΎΠ΄Ρ–Π² Ρ‚Π° Ρ€Π΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°Ρ†Ρ–ΠΉ для ΠΎΡ€Π³Π°Π½Ρ–Π² Π²Π»Π°Π΄ΠΈ ΠΏΠΎ Ρ€ΠΎΠ·Π±ΡƒΠ΄ΠΎΠ²Ρ– Π†ΠšΠ’ Π· ΠΌΠ΅Ρ‚ΠΎΡŽ забСзпСчСння ΡΡ‚Π°Π±Ρ–Π»ΡŒΠ½ΠΎΠ³ΠΎ Π΅ΠΊΠΎΠ½ΠΎΠΌΡ–Ρ‡Π½ΠΎΠ³ΠΎ зростання ΠΊΡ€Π°Ρ—Π½ΠΈ. ΠŸΡ€ΠΈ Ρ†ΡŒΠΎΠΌΡƒ Π²ΠΈΠΎΠΊΡ€Π΅ΠΌΠ»Π΅Π½ΠΎ основні ΠΏΡ€ΠΈΠ½Ρ†ΠΈΠΏΠΈ Ρ€ΠΎΠ·Π²ΠΈΡ‚ΠΊΡƒ Π†ΠšΠ’, які ΠΌΠ°ΡŽΡ‚ΡŒ Π±ΡƒΡ‚ΠΈ засновані Π½Π° ΠΏΡ–Π΄Ρ…ΠΎΠ΄Π°Ρ… Ρ€ΠΈΠ½ΠΊΠΎΠ²ΠΎΠ³ΠΎ співробітництва ΠΌΡ–ΠΆ Π΄Π΅Ρ€ΠΆΠ°Π²Π½ΠΈΠΌΠΈ Ρ– ΠΏΡ€ΠΈΠ²Π°Ρ‚Π½ΠΈΠΌΠΈ Π½Π°ΡƒΠΊΠΎΠ²ΠΎ-дослідними Ρ†Π΅Π½Ρ‚Ρ€Π°ΠΌΠΈ ΠΊΡ€Π°Ρ—Π½ΠΈ, Π· ΠΌΠ΅Ρ‚ΠΎΡŽ підвищСння СфСктивності впровадТСння Ρ–Π½Π½ΠΎΠ²Π°Ρ†Ρ–ΠΉ Ρƒ Π³Π°Π»ΡƒΠ·Ρ– Π†ΠšΠ’. Π’ΠΈΠΊΠΎΡ€ΠΈΡΡ‚ΠΎΠ²ΡƒΡŽΡ‡ΠΈ Π΅ΠΊΠΎΠ½ΠΎΠΌΡ–ΠΊΠΎ-статистичні ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈ, Π°Π²Ρ‚ΠΎΡ€ΠΈ ΠΎΡ†Ρ–Π½ΠΈΠ»ΠΈ взаємозв’язок ΠΌΡ–ΠΆ Π΅Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½Ρ–ΡΡ‚ΡŽ функціонування Π†ΠšΠ’ Ρ‚Π° Π΅ΠΊΠΎΠ½ΠΎΠΌΡ–Ρ‡Π½ΠΈΠΌ зростанням ΠΊΡ€Π°Ρ—Π½ΠΈ. Автори ΠΏΡ–Π΄ΠΊΡ€Π΅ΡΠ»ΡŽΡŽΡ‚ΡŒ, Ρ‰ΠΎ Π²ΠΏΠ»ΠΈΠ² Π†ΠšΠ’ Π½Π° Π΅ΠΊΠΎΠ½ΠΎΠΌΡ–ΠΊΡƒ ΠΊΡ€Π°Ρ—Π½ΠΈ Π²Ρ–Π΄Ρ‡ΡƒΠ²Π°Ρ”Ρ‚ΡŒΡΡ як Π½Π° ΠΌΠ°ΠΊΡ€ΠΎ-, Ρ‚Π°ΠΊ Ρ– макрорівнях: Π²ΠΎΠ½ΠΈ Π²ΠΏΠ»ΠΈΠ²Π°ΡŽΡ‚ΡŒ Π½Π° процСс ΠΎΡ†Ρ–Π½ΠΊΠΈ Ρ–Π½Ρ„ΠΎΡ€ΠΌΠ°Ρ†Ρ–Ρ— Ρ– знань; Π°Π²Ρ‚ΠΎΠΌΠ°Ρ‚ΠΈΠ·ΡƒΡŽΡ‚ΡŒ Ρ‚Π° ΠΏΡ€ΠΈΡΠΊΠΎΡ€ΡŽΡŽΡ‚ΡŒ Π²ΠΈΡ€ΠΎΠ±Π½ΠΈΡ‡Ρ– Ρ†ΠΈΠΊΠ»ΠΈ, Π·Π½ΠΈΠΆΡƒΡŽΡ‚ΡŒ Π²ΠΈΡ€ΠΎΠ±Π½ΠΈΡ‡Ρ– Π²ΠΈΡ‚Ρ€Π°Ρ‚ΠΈ; Π²ΠΈΡΡ‚ΡƒΠΏΠ°ΡŽΡ‚ΡŒ нСвід’ємним ΠΊΠΎΠΌΡƒΠ½Ρ–ΠΊΠ°Ρ†Ρ–ΠΉΠ½ΠΈΠΌ інструмСнтом ΡΡƒΡΠΏΡ–Π»ΡŒΡΡ‚Π²Π°, нСурядових ΠΎΡ€Π³Π°Π½Ρ–Π·Π°Ρ†Ρ–ΠΉ Ρ‚Π° підприємств.This article capitalizes possible impacts of ICT to the economy of Armenia with forecasts and distinction with ICT related succeeding several countries. It is introduced in article the current situation in Armenia and gives policy recommendations. Pointed in article, that the world economy is transforming from an industrial age to an informational/knowledge based age, where the role of ICT is becoming increasingly powerful and vital compared to labor force and capital. The article aims to show that Armenia with its objective and subjective economic and political problems could become developed and wealthy with well-built ICT industry promoted strategy. Authors suggest the recommendations to the Government of Armenia needs in establishment of healthy operation of the political-economic body of the country based on market-oriented cooperation between public-private and research development centers/educational sectors of the country to better utilize the benefits of ICT industry. It is noticed in article, about the important role of several indicators that have been developed by international organizations and consulting companies to assess the correlation between ICT and economic growth as well as the major factors of ICT growth. Authors emphasis the impacts of ICT on a country are on both levels of the economy: macro and micro levels. On the macro level of national economy, ICT impacts the information and knowledge assessment process; speeds up and reduces the costs of production and transactions; and connects people, NGOs, enterprises, and communities. Bellow in article, is presented the cases of several countries for better illustration of the economic, political and social benefits of ICT industry growth. It is pointed that that the ICT industry has become the carrier of modern national economy development: the country is better equipped, it would better benefit from the process taking place in the world market

    Prophylaxis of fibroids recurrence after conservative myomectomy in reproductive period

    Get PDF
    Conservative myomectomy is the unique treatment for women of reproductive period. Therefore it's very important to prevent recurrence of fibroids by individual antirecurrent treatment. Were examined 75 women, average age 32,4 Β± 3,1 years, duration disease (fibroids) 4,29Β±1,5 years (from 2 to 7 years). Initial diameter of fibroids 45,82Β±20,76 mm, after conservative myomectomy 16,55Β±2,56 ΠΌΠΌ. Number of fibroids /per woman 5,18Β±2,5. Pharmacotherapy were provided with agonists of GnRH agonists, intrauterine levonorgestrel containing the depot - the system, antiprogestins. No significant deferens of efficiency depended from type of pharmacotherapy was found: decreased of volume of uterus, number of fibroids nodes, diameter of dominant node

    MANAGEMENT OF PREGNANCY AND LABOR IN MYOPIC PATIENTS

    Get PDF
    Aim. To study the course of pregnancy and labor in women suffering from myopia.Materials and methods. A comparative analysis of pregnancy outcomes among 100 women with myopia was held. There were 48 women in the study group who had a retinal laser correction within the period of pregnancy. The control group was represented by 52 women who did not undergo the correction.Results. We noted that the peripheral laser retinopexy made possible labor through natural birth canals for women of the study group. While the control group of women underwent abdominal delivery.Conclusion. The problem of myopia during pregnancy remains the focus of attention of obstetricians and ophthalmologists, since it is very important to choose the optimal method of delivery. In this case it is necessary to take into account not only the degree of myopia, but also the state of the retina. Peripheral vitreochorioretinal dystrophic changes (PVCDC) are indication for cesarean section. It was found that the timely use of LRP for retina makes possible reducing the percentage of surgical delivery, and thereby reduces the risk of post-surgery complications

    Probability distributions on Banach spaces

    No full text
    corecore